Wednesday, August 20, 2008

Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer

Summary  Taxanes are among the most active agents and they are now known to be an indispensable component in chemotherapy for breast cancer. However, some patients are resistant to taxanes and the identification of the molecular characte

No comments: